Johnson & Johnson vs United Therapeutics Corp
JNJ vs UTHR — side-by-side comparison from reported financials. JNJ leads 4, UTHR leads 5 of 9 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
| Metric | JNJ | UTHR |
|---|---|---|
| Price | $261.79 | $549.16 |
| Market cap | $631B | $23.6B |
| Revenue (TTM) | $97.9B | $3.15B |
| Revenue growth | +5.6% | +18.0% |
| Net margin | 21.5% | 41.6% |
| Free cash flow | $22.2B | $1.09B |
| Net cash (debt) | ($27.8B) | $2.88B |
| 1-year price return | +37.0% | +23.3% |
| P/E | 29.9 | 18.0 |
| P/E vs own history (cheap-side %) | 16% | 26% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 20% |
| Altman Z-score | — | 21.46 |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 1,400 |
Full résumé-style profiles: JNJ CV · UTHR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.